Catches my eye Phase 1/2 $tptx takeout at $3.5 billion. Solid tumors and lung cancer are a big indication obviously but takeout this early by $bmy shows the value once a buyer can kick tires and get comfortable. They do risk reward just like we talk about all the time. $snpx shows promise in Phase 2 or a smart buyer looks at the peer review analysis …